Myovant Sciences Ltd. (MYOV) Comparison with companies in other sectors?

Myovant Sciences Ltd. has a share price of 97.26M. You can analyze Myovant Sciences Ltd. (MYOV) competitors across different market sectors through stock heatmaps.

What are MYOV's NET and operating margins?

Myovant Sciences Ltd. (MYOV) operating margin is around -0.81, and net profit margin is approximately -0.89 as of the latest reports.

In what way does MYOV's earnings per share (EPS) trend reflect its financial momentum?

Myovant Sciences Ltd. (MYOV) EPS is -1.92 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Myovant Sciences Ltd. is -14.05, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Myovant Sciences Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Myovant Sciences Ltd. like P/E which is -12.18, P/B which is -5.30, and PEG which is -0.12. Compare them with sector averages to evaluate if the stock is priced fairly.

Myovant Sciences Ltd.

MYOV•NYSE

Healthcare

Biotechnology

$26.98

$-0.01(-0.04%)

Fundamental Analysis of Myovant Sciences Ltd. (MYOV)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-1.92

P/E Ratio

-14.05

ROE

0.50%

Net Margin

-0.89%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$2.62B

Shares OutstandingTotal number of shares issued

$97.26M

Book Value/ShareNet worth per share

$-5.09

Revenue/ShareAnnual revenue per share

$2.48

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-1.92

Net MarginNet income as percentage of revenue

-89.18%

Operating MarginOperating income as percentage of revenue

-81.11%

ROEReturn on shareholders' equity

49.79%

ROAReturn on total assets

-39.61%

ROCEReturn on capital employed

-69.47%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-2.90

Cash/ShareCash and equivalents per share

$4.67

FCF YieldFree cash flow as percentage of market cap

-10.27%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for MYOVFinancial Ratios Analysis details for MYOV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for MYOVSector Benchmarking details for MYOV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Myovant Sciences Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Myovant Sciences Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Myovant Sciences Ltd.'s unique business strengths and challenges.

Key Financial Metrics for Myovant Sciences Ltd.

For Myovant Sciences Ltd., essential financial indicators include EPS -1.92, PE -14.05, and ROE 0.50. These key ratios reveal insights into Myovant Sciences Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Myovant Sciences Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Myovant Sciences Ltd.

Metrics like Net Margin -89.18% and ROA -39.61% shed light on how well Myovant Sciences Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Myovant Sciences Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of Myovant Sciences Ltd.

Using ratios such as P/B Ratio -5.30 and PEG Ratio -0.12, investors can assess whether Myovant Sciences Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with Myovant Sciences Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Myovant Sciences Ltd.

Financial health indicators, such as Debt/Equity Ratio -0.78 and Cash Flow $-2.90, provide a snapshot of Myovant Sciences Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Myovant Sciences Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Myovant Sciences Ltd.

Investing in Myovant Sciences Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Myovant Sciences Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;